Related Experiment Video
Updated: Aug 5, 2026

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Cantú Syndrome: A Poorly Understood Multi-Organ Disorder
Shuijing He1,2, Dan Hu1,2, Colin G Nichols3,4
1Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Cantú syndrome (CS) is a rare genetic disorder affecting multiple organs. This review summarizes current knowledge on CS epidemiology, diagnosis, and treatment to improve awareness and understanding of this complex condition.
Area of Science:
- Genetics and rare diseases
- Molecular biology
- Clinical medicine
Background:
- Cantú syndrome (CS) is a rare multisystem disorder.
- Characterized by hypertrichosis, facial dysmorphism, cardiomegaly, and skeletal abnormalities.
- Limited understanding and high misdiagnosis rate due to diverse manifestations.
Purpose of the Study:
- To summarize current knowledge on Cantú syndrome.
- To raise awareness and improve understanding of CS.
- To cover epidemiology, definition, clinical features, diagnosis, and treatment.
Main Methods:
- Literature review of reported knowledge on Cantú syndrome.
- Synthesis of information on CS epidemiology, clinical features, diagnosis, and treatment.
- Focus on genetic basis and KATP channel mutations.
Main Results:
- CS is an autosomal dominant disorder linked to KATP channel mutations.
- Clinical features are diverse, including hypertrichosis, dysmorphism, and organomegaly.
- No specific treatments are currently available.
Conclusions:
- There is a need for increased awareness and education on Cantú syndrome.
- Further research into CS mechanisms and therapeutic strategies is essential.
- Early and accurate diagnosis is crucial for patient management.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Other Disorders of Digestive System
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
